A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2011
12/21/2011	CN102018666B 一种喷昔洛韦注射液的制备方法及临床新用途 One kind of penciclovir injection preparation method and new clinical uses
12/21/2011	CN101953778B Folate-targeted hydrophobic medicine-loaded polymeric vesicle and preparation method and use thereof
12/21/2011	CN101940551B 一种巯基化壳聚糖季胺盐自组装纳米粒、其制备方法及应用 One kind of thiolated chitosan nanoparticles self-assembled quaternary ammonium salt, its preparation method and application
12/21/2011	CN101926822B 一种二氧化硅介孔材料在制备重金属中毒的解毒药物中的应用 One silica mesoporous materials in the manufacture of heavy metal poisoning antidote in
12/21/2011	CN101914226B 一种药物缓释用壳聚糖/凹土复合材料的制备方法 A drug delivery using chitosan / Au composite soil preparation
12/21/2011	CN101864071B 聚乙二醇-二硬脂酰磷脂酰乙醇胺衍生物及其制备方法 Polyethylene glycol - distearoyl phosphatidyl ethanolamine derivatives and preparation method
12/21/2011	CN101862363B 人参总皂苷初级渗透泵片及其制备方法 TSPG primary osmotic pump tablets and preparation method
12/21/2011	CN101843593B 一种维库溴铵冻干制剂及其制备方法 One kind of vecuronium lyophilized formulation and preparation method
12/21/2011	CN101843582B 紫杉醇纳米混悬剂及其制备方法 Taxol nanosuspension and its preparation method
12/21/2011	CN101812157B 聚(n-异丙基丙烯酰胺)/凹凸棒土复合水凝胶的合成方法 Synthesis of poly (n- isopropylacrylamide) / attapulgite composite hydrogel
12/21/2011	CN101780258B 一种无蔗糖型参梅养胃颗粒及其制备方法 A non-parametric sugar plum stomach particle and its preparation method
12/21/2011	CN101780029B 安妥沙星口服制剂及其用途 Clofibrate gatifloxacin oral formulations and their use
12/21/2011	CN101732275B 一种单硝酸异山梨酯双层渗透泵控释片及其制备方法 A single-isosorbide dinitrate layer osmotic pump tablets and preparation method
12/21/2011	CN101633698B 一种免疫融合蛋白及其编码基因与应用 A protein coding gene and application of immunological fusion
12/21/2011	CN101623268B 一种血管内皮生长因子单克隆抗体Avastin壳聚糖纳米粒制剂 One kind of vascular endothelial growth factor monoclonal antibody Avastin chitosan nanoparticles formulation
12/21/2011	CN101574326B 一种含替加氟、吉美斯他和氧嗪酸钾的胶囊制剂及其制备方法 An tegafur, Kyrgyzstan Gomez him and oteracil potassium-containing capsule and its preparation method
12/21/2011	CN101565465B 一种抗刚地弓形虫表面抗原1人源抗体Fab片段及其编码基因 An anti-Toxoplasma gondii surface antigen a human antibody Fab fragments and coding gene
12/21/2011	CN101524411B 大容量苦黄注射液及其制备方法 Large capacity Kuhuang injection and its preparation method
12/21/2011	CN101407624B 增稠剂混合组合物及使水性体系增稠的方法 Thickeners composition and method of making the aqueous systems thickened
12/21/2011	CN101310712B 一种硝苯地平控释制剂及其制备方法 One kind of nifedipine and its preparation method
12/21/2011	CN101176785B 一种重组双功能水蛭素口服制剂及其制备方法 A bifunctional hirudin recombinant oral preparation and preparation method
12/20/2011	US8080650 Pro104 antibody compositions and methods of use
12/20/2011	US8080641 Process for the production of multiple cross-linked hyaluronic acid derivatives
12/20/2011	US8080586 Self-emulsifying preparations
12/20/2011	US8080578 Methods for treatment with bucindolol based on genetic targeting
12/20/2011	US8080431 Nanoparticles
12/20/2011	US8080263 Dispersion for pulmonary delivery of a bioactive agent
12/20/2011	US8080236 Particulate materials
12/20/2011	CA2733294C Pharmaceutical combination of a tiotropium salt and ciclesonide
12/20/2011	CA2530619C Non-gelatin film and method and apparatus for producing same
12/20/2011	CA2381143C Dendrimer-photosensitizer complexes for medical applications
12/20/2011	CA2202028C Tie-2 ligands, methods of making and uses thereof
12/15/2011	WO2011156711A1 Nanoparticle film delivery systems
12/15/2011	WO2011156663A1 Method of treating a material using a sol-gel derived composition
12/15/2011	WO2011156481A2 Formulations including amiodarone and salts thereof and methods of their manufacture and use
12/15/2011	WO2011156410A1 Conjugated polymeric material and uses thereof
12/15/2011	WO2011156328A1 Cysteine engineered antibodies and conjugates
12/15/2011	WO2011156242A2 Improved anti-lysophospholipid antibody design using antibody structures
12/15/2011	WO2011156119A1 Combination therapy methods for treating proliferative diseases
12/15/2011	WO2011155800A2 Deacetylation hydrolase of hyaluronic acid, hyaluronic acid deacetylated by same and derivative thereof
12/15/2011	WO2011155640A1 Antimycotic pharmaceutical composition
12/15/2011	WO2011155501A1 Pharmaceutical multimeric particles, and manufacturing method for same
12/15/2011	WO2011155451A1 Coated particle and method for producing coated particle
12/15/2011	WO2011154985A1 Ophthalmic compositions for the administration of liposoluble acitve ingredients
12/15/2011	WO2011154803A1 An enzymatic method of producing a hydrogel from xylan
12/15/2011	WO2011154725A2 Compositions
12/15/2011	WO2011154724A2 Compositions
12/15/2011	WO2011154711A1 Peptide-carrying nanoparticles
12/15/2011	WO2011154505A2 Complex product comprising a cellular carrier and a cytoxic chemotherapeutic drug
12/15/2011	WO2011154444A1 Novel process
12/15/2011	WO2011154418A1 Preparation for vaginal and rectal use and relative production method
12/15/2011	WO2011154349A2 Fgf21 analogues and derivatives
12/15/2011	WO2011154331A1 Polymers for delivery of nucleic acids
12/15/2011	WO2011154004A1 A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
12/15/2011	WO2011153959A1 Conjugates of flu virus m2 or ha2 fragments and protein carriers, and pharmaceutical use thereof
12/15/2011	WO2011107466A3 Melt-coated pharmaceutical forms
12/15/2011	WO2011097384A3 Tumor targeted delivery of immunomodulators by nanoplymers
12/15/2011	WO2011093833A3 Effervescent formulations comprising second generation cephalosporin
12/15/2011	WO2011091376A3 Immunogenic influenza composition
12/15/2011	WO2011091065A3 Synthetic nanostructures including nucleic acids and/or other entities
12/15/2011	WO2011034551A3 Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle
12/15/2011	WO2011022737A3 Process for manufacturing tablets by using a fluent and settable matrix, and tablets obtained therewith
12/15/2011	WO2011008770A3 Methods for inhibiting yellow color and peroxide formation in a composition
12/15/2011	WO2010145849A3 Drug delivery systems
12/15/2011	US20110306680 Compositions containing agar and esterified sugar surfactants
12/15/2011	US20110306677 Pressure Sensitive Adhesive Composition and Pressure Sensitive Adhesive Tape
12/15/2011	US20110306657 Polyalkyleneimine-graft-biodegradable polymers for delivery of bioactive agents
12/15/2011	US20110306656 Biologically tolerated low molecular weight polyethylenimines
12/15/2011	US20110306649 Prodrugs of ion channel modulating compounds and uses thereof
12/15/2011	US20110306630 Pharmaceutical compositions comprising colloidal silicon dioxide
12/15/2011	US20110306582 Androgen pharmaceutical composition and method for treating depression
12/15/2011	US20110306544 Methods and formulations for increasing intestinal function
12/15/2011	US20110306539 Process for making particles for delivery of drug nanoparticles
12/15/2011	US20110306500 Method of Treating a Material Using a Sol-gel Derived Composition
12/15/2011	US20110305770 Releasable polymeric lipids for nucleic acids delivery system
12/15/2011	US20110305768 Quick-dissolving oral thin film for targeted delivery of therapeutic agents
12/15/2011	US20110305767 Polymer Particles Prepared From Polymerisable Alkylene Glycol (Meth) Acrylate Monomers
12/15/2011	US20110305764 Use of a Mare's Milk Concentrate Dried on a Highly-Dispersed, Biologically Inert Matrix
12/15/2011	US20110305739 Method for Preparing a Non-Ionic Surfactant Stable Personal Care Dispersion
12/15/2011	US20110305730 Mono-and disaccharide derivatives
12/15/2011	US20110305723 Molecular Antigen Array
12/15/2011	US20110305665 Pegylated interleukin-10
12/15/2011	US20110305652 Anionic Surfactant Stable Cocoamide Monoethanolamine (CMEA) Composition
12/15/2011	CA2807271A1 Nanoparticle film delivery systems
12/15/2011	CA2802184A1 Oral iron deficiency therapy
12/15/2011	CA2802162A1 Ophthalmic compositions for the administration of liposoluble acitve ingredients
12/15/2011	CA2802031A1 Peptide-carrying nanoparticles
12/15/2011	CA2802005A1 Compositions comprising buprenorphine
12/15/2011	CA2801984A1 Novel process
12/15/2011	CA2801891A1 Combination therapy methods for treating proliferative diseases
12/15/2011	CA2801716A1 Conjugated polymeric material and uses thereof
12/15/2011	CA2801676A1 Compositions
12/15/2011	CA2800181A1 A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
12/15/2011	CA2799540A1 Cysteine engineered antibodies and conjugates
12/14/2011	EP2395041A1 Polymers for delivery of nucleic acids
12/14/2011	EP2395014A2 Silk proteins
12/14/2011	EP2395012A2 Modified siRNA molecules and uses thereof
12/14/2011	EP2394666A2 Pharmaceutical compositions comprising tgf- beta 1 inhibitor peptides
12/14/2011	EP2394665A1 Cell-penetrating peptides and uses therof
12/14/2011	EP2394664A1 Antipsychotic injectable depot composition

1 ... 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 ... 1712